Russian Extreme Hypertriglyceridemia Registry

The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care.

NCT Number	NCT07508930
Lead Sponsor	Russian Cardiology Research and Production Center Collaborators: Research Centre for Medical Genetics, Russian Federation
Conditions	Hypertriglyceridemia
Enrollment	500 participants
Start Date	2025-11-20
Primary Completion	2045-12 (estimated)
Study Completion	2045-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-02